Therapeutic Nanoparticles Offer Potential as Cancer-Killers
A research team at Commerce’s National Institute of Standards and Technology (NIST) studying sugar-coated nanoparticles for use as a possible cancer therapy, has uncovered a delicate balancing act that makes the particles more effective than conventional thinking says they should be. In cooperation with The Johns Hopkins University, Dartmouth College, the University of Manitoba and two biopharmaceutical companies, the NIST team has demonstrated that the particles are potent cancer-killers because they interact with one another in ways that smaller nanoparticles do not. Click on NIST logo above for image and description or here. (More)










